LIXTE and Liora Unite to Revolutionize Cancer Treatment with Combined Therapies
March 16, 2026 — LIXTE Biotechnology and Liora Technologies partner to combine LB-100 and advanced cancer treatments, aiming for more effective, affordable patient outcomes in oncology.